SAN DIEGO — GLP-1 agonists may be protective against hip fracture when administered for the treatment of type 2 diabetes, according to results presented here.“This study supports other studies showing that GLP-1s can have a positive effect on bone mineral density by showing that patients that are treated with these have a lower incidence of hip fracture,” John C. Hagedorn II, MD, FAAOS, orthopedic trauma surgeon at the University of Texas Medical Branch in Galveston, Texas, told Healio.Using the TriNetX database, Hagedorn and colleagues categorized patients aged 65 years or
Read More